CN Patent

CN115698290A — 用于治疗神经系统疾病的补体组分4抑制剂以及使用它们的相关组合物、系统和方法

Assigned to Genentech Inc · Expires 2023-02-03 · 3y expired

What this patent protects

本发明涉及在神经系统疾病的治疗中使用的补体组分4(C4)抑制剂。本发明特别地涉及C4抑制剂用于C4表达的下调的用途。本发明还涉及与C4A和/或C4B互补并能够降低C4A和/或C4B mRNA的水平的核酸分子。本发明还包括药物组合物及其在神经系统疾病的治疗中的用途。

USPTO Abstract

本发明涉及在神经系统疾病的治疗中使用的补体组分4(C4)抑制剂。本发明特别地涉及C4抑制剂用于C4表达的下调的用途。本发明还涉及与C4A和/或C4B互补并能够降低C4A和/或C4B mRNA的水平的核酸分子。本发明还包括药物组合物及其在神经系统疾病的治疗中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN115698290A
Jurisdiction
CN
Classification
—
Expires
2023-02-03
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.